Invasive fungal infections

Article Sidebar

PDF HTML
Published: 2022-09-19
DOI: https://doi.org/10.7196/AJTCCM.2022.v28i3.264

Main Article Content

S Kwarteng Owusu
Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti Region, Ghana

Abstract

-

Downloads

Download data is not yet available.

Article Details

Issue

AJTCCM Vol. 28 No. 3

Section

Editorials
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain copyright and grant the journal right of first publication.

How to Cite

1.
Kwarteng Owusu S. Invasive fungal infections. Afr J Thoracic Crit Care Med [Internet]. 2022 Sep. 19 [cited 2026 Apr. 30];28(3):100-1. Available from: https://samajournals.co.za/index.php/ajtccm/article/view/235

References

Spellberg B. Vaccines for invasive fungal infections. F1000 Med Rep 2011;3:13. https:// doi.org/10.3410/M3-13.

Kaushik N, Pujalte GG, Reese ST. Superficial fungal infections. Prim Care Clin Off Pract 2015;42:501-516.

Hobson RP. The global epidemiology of invasive Candida infections: Is the tide turning? J Hosp Infect 2003:55:159-168.

Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol 2010;28(2):197-201. https://10.1016/j.clindermatol.2009.12.005.

Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: Human fungal infections. Sci Transl Med 2012;4(165):165rv13.

Hlophe ST, Jeena P, Mahabeer Y, Govender N, Masekela R, Ogunsakin RE. Invasive fungal infections in a paediatric intensive care unit in a lower- to middle-income country. Afr J Thoracic Crit Care Med 2022;28(3):x-x. https://doi.org/10.7196/ AJTCCM.2022.v28i3.xx

Filioti J, Spiroglou K, Roilides E. Invasive candidiasis in pediatric intensive care patients: Epidemiology, risk factors, management, and outcome. Intensive Care Med 2007;33: 1272-1283.

Zaoutis TE, Heydon K, Localio R, Walsh TJ, Feudtner C. Outcomes attributable to neonatal candidiasis. Clin Infect Dis 2007;44:1187-1193.

Kelly MS, Benjamin DK, Smith PB. The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol 2015;42(1):105-117. https://doi. org/ 10.1016/j.clp.2014.10.008

Park B, Wannemuehler K, Marston B. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23(4):525- 530. https://doi.org/10.1097/QAD.0b013e328322ffac

Mennink-Kersten MA, Verweji PE. Non-culture-based diagnostics for opportunistic fungi. Infect Dis Clin 2006;20(3):711-727.

Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: A 10-year review. Pediatr Radiol 2003;33:453-460.

Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndromes. Clin Infect Dis 2004;39(2):199-205. https://doi.org/10.1086/421944

Zaoutis TE, Jafri HS, Huang LM, et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics 2009;123(3):877-884.

Queiroz-Telles F, Berezin E, Leverger G, et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: Substudy of a randomized double-blind trial. Pediatr Infect Dis J 2008;27(9):820-826.

Nett J, Andes DR. Antifungal agents: Spectrum of activity, pharmacology, and clinical indications. Infect Dis Clin North Am 2016;30(1):51-83. https://doi.org/10.1016/j. idc.2015.10.012

Cadena J, Thompson GR, Patterson TF. Invasive aspergillosis: Current strategies for diagnosis and management. Infect Dis Clin North Am 2016;30(1):125-142. https:// doi.org/10.1016/j.idc.2015.10.015

Dornbusch HJ, Manzoni P, Rollides E, Walsh TJ, Groll AH. Invasive fungal infections in children. Pediatr Infect Dis J 2009;28(8):734-737.